Published in Conn Med on March 01, 2013
Inclusion body myositis. Neurol Clin (2014) 0.83
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol (2006) 4.22
Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol (2008) 3.14
Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib. J Clin Oncol (2008) 2.38
Immunotherapy for melanoma: current status and perspectives. J Immunother (2010) 1.72
Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature. Br J Haematol (2011) 1.69
Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients. Clin Cancer Res (2009) 1.65
Update on managing diaphragmatic rupture in blunt trauma: a review of 208 consecutive cases. Can J Surg (2009) 1.61
Imaging of renal lymphoma: patterns of disease with pathologic correlation. Radiographics (2006) 1.52
Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia. Dermatol Online J (2011) 1.49
Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches. Expert Opin Biol Ther (2013) 1.44
Malignant melanoma in pigmented skin: does the current interventional model fit a different clinical, histologic, and molecular entity? Dermatol Surg (2013) 1.41
Inflammatory and immune-related conditions associated with Waldenström macroglobulinemia: a single center experience. Leuk Lymphoma (2014) 1.39
High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse (2006) 1.30
Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol (2010) 1.19
Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure. Synapse (2008) 1.17
Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase. Antimicrob Agents Chemother (2004) 1.13
Peripheral blood immunophenotypic analysis as a diagnostic tool for large granular lymphocyte leukemia. Leuk Lymphoma (2012) 1.07
A case of polycythemia rubra vera transforming into chronic phase JAK2 V617F mutation-negative Philadelphia chromosome-positive chronic myelogenous leukemia. Leuk Lymphoma (2013) 1.06
Gene-environment interactions in Parkinson's disease and other forms of parkinsonism. Neurotoxicology (2010) 1.06
Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates. J Gastrointest Cancer (2012) 1.05
HIV-1 progression links with viral genetic variability and subtype, and patient's HLA type: analysis of a Nairobi-Kenyan cohort. Med Microbiol Immunol (2013) 1.04
Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review. Curr Med Res Opin (2013) 1.03
Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP (2011) 1.03
Tumor vaccines in 2010: need for integration. Cell Immunol (2010) 1.02
Genetic analysis of HIV-1 subtypes in Nairobi, Kenya. PLoS One (2008) 1.00
Lasers, stem cells, and COPD. J Transl Med (2010) 0.95
Ketamine-induced neurotoxicity and changes in gene expression in the developing rat brain. Curr Neuropharmacol (2011) 0.92
Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity. Ann N Y Acad Sci (2003) 0.92
Does bortezomib induce de facto varicella zoster virus reactivation in patients with multiple myeloma? J Clin Oncol (2009) 0.91
Immune alterations in malignant melanoma and current immunotherapy concepts. Expert Opin Biol Ther (2013) 0.91
Details of left ventricular remodeling and the mechanism of paradoxical ventricular septal motion after coronary artery bypass graft surgery. J Invasive Cardiol (2011) 0.89
Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity. South Med J (2010) 0.89
Dura-based cavernous hemangioma presenting as large intracerebral hematoma in a child: A rare clinico-pathological entity. J Pediatr Neurosci (2011) 0.88
Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST. Dermatol Online J (2008) 0.87
Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr Med Res Opin (2012) 0.86
Malignant melanoma in African-Americans. Dermatol Online J (2009) 0.86
Reliability of sonographic assessment of tendinopathy in tennis elbow. Skeletal Radiol (2011) 0.85
Links between nutrition, drug abuse, and the metabolic syndrome. Ann N Y Acad Sci (2006) 0.85
Fine-needle aspiration biopsy of secondary neoplasms of the thyroid gland: a multi-institutional study of 62 cases. Cancer Cytopathol (2014) 0.85
Autoimmune manifestations in large granular lymphocyte leukemia. Clin Lymphoma Myeloma Leuk (2012) 0.85
A rare tumour in a rare location: desmoplastic fibroma in a toe. Foot Ankle Surg (2011) 0.85
Food, nutrigenomics, and neurodegeneration--neuroprotection by what you eat! Mol Neurobiol (2013) 0.84
An unusual presentation of a carcinoid tumor of the common bile duct. JOP (2013) 0.84
Second primary pancreatic adenocarcinoma three years after successfully treated index esophageal cancer. JOP (2014) 0.84
Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma. Expert Opin Pharmacother (2011) 0.83
Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology. Hum Pathol (2009) 0.83
Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out. Vasc Health Risk Manag (2011) 0.83
Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation. Neuropharmacology (2010) 0.83
Neuroprotective effect of resveratrol against methamphetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity. Curr Neuropharmacol (2011) 0.83
Normal values of regional and global myocardial wall motion in young and elderly individuals using navigator gated tissue phase mapping. Age (Dordr) (2013) 0.83
Hepatoid variant of pancreatic cancer: insights from a case and literature review. JOP (2013) 0.83
Modulation of the FGF14:FGF14 homodimer interaction through short peptide fragments. CNS Neurol Disord Drug Targets (2014) 0.82
Acute gout during treatment with paclitaxel for metastatic melanoma. Rheumatology (Oxford) (2009) 0.82
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med (2011) 0.81
Fluorodeoxyglucose-induced allergic reaction: a case report. J Oncol Pharm Pract (2012) 0.81
Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide. Leuk Res (2011) 0.81
Talonavicular dislocation with associated cuboid fracture following low-energy trauma. Foot Ankle Surg (2008) 0.80
Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nanoparticles in nanomedicine. Drug Metab Rev (2014) 0.80
Population-specific evolution of HIV Gag epitopes in genetically diverged patients. Infect Genet Evol (2013) 0.80
On the missing link between inflammation and cancer. Dermatol Online J (2011) 0.80
The cutaneous epidermal growth factor network: Can it be translated clinically to stimulate hair growth? Dermatol Online J (2009) 0.80
The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Ann N Y Acad Sci (2002) 0.80
Plug-and-Play Tool Handles for Laparoscopic Surgery Simulators. Stud Health Technol Inform (2009) 0.80
Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations. Surg Obes Relat Dis (2013) 0.80
Western variant of brain intravascular lymphoma displaying three distinct evolutive radiologic stages. Conn Med (2014) 0.79
High-grade solitary extramedullary plasmacytoma arising in skeletal muscle of a kidney transplant recipient. Leuk Res (2011) 0.79
Exogenous endothelial cells as accelerators of hematopoietic reconstitution. J Transl Med (2012) 0.79
Cholangiocarcinoma and paraneoplastic hypercalcemia: a lethal combination revisited. South Med J (2010) 0.79
Effect of genistein on p90RSK phosphorylation and cell proliferation in T47D breast cancer cells. Anticancer Res (2011) 0.79
Neuroleptic malignant syndrome with aripiprazole and lithium: a case report. J Clin Psychopharmacol (2006) 0.79
Synchronous tumors: adenosquamous carcinoma of pancreas and GIST of stomach. J Gastrointest Cancer (2011) 0.79
Kidney cancer therapy: new perspectives and avenues. Expert Opin Pharmacother (2006) 0.79
Nano-drug delivery and neuroprotection in spinal cord injury. J Nanosci Nanotechnol (2009) 0.79
Adult biphasic pulmonary blastoma. Conn Med (2013) 0.79
Acute Generalized Exanthematous Pustulosis Induced by Erlotinib (Tarceva) with Superimposed Staphylococcus aureus Skin Infection in a Pancreatic Cancer Patient: A Case Report. Case Rep Oncol (2012) 0.78
Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies. Thyroid (2008) 0.78
Modulations of cell cycle checkpoints during HCV associated disease. BMC Infect Dis (2009) 0.78
Immune alterations and immunotherapy prospects in head and neck cancer. Expert Opin Biol Ther (2013) 0.78
Acute Wernicke encephalopathy and sensorineural hearing loss complicating bariatric surgery. Conn Med (2012) 0.78
Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide. Leuk Res (2010) 0.78
Factors prompting sneezing in intravenously sedated patients receiving local anesthetic injections to the eyelids. Ophthalmology (2010) 0.78
Immune alterations in untreated and treated myelodysplastic syndrome. Expert Opin Drug Saf (2011) 0.77
HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence? Ann Hematol (2014) 0.77
Hepatitis associated aplastic anemia: case report and discussion. Conn Med (2014) 0.77
Burden of communicable disease among the native and repatriating Afghans. PLoS Pathog (2012) 0.77
Neuroblastoma with a solitary intraventricular brain metastasis visualized on I-123 MIBG scan. J Neuroimaging (2012) 0.77
Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma. Expert Opin Pharmacother (2013) 0.77
What are the latest pharmacotherapy options for small bowel adenocarcinoma? Expert Opin Pharmacother (2014) 0.77
Gastrointestinal stromal tumor of small intestine and synchronous bilateral papillary renal cell carcinoma. Conn Med (2013) 0.77
Diagnostic Accuracy of MRI in Predicting Breast Tumor Size: Comparative Analysis of MRI vs Histopathological Assessed Breast Tumor Size. Conn Med (2015) 0.77
Generalized cerebral atrophy seen on MRI in a naturally exposed animal model for Creutzfeldt-Jakob disease. J Transl Med (2010) 0.76
Anaphylactic reactions with intravenous vitamin K: lessons from the bedside. Conn Med (2012) 0.76
Methotrexate therapy leading to a rapid progression of a previously indolent prostate cancer: is immunosuppression to blame? J Oncol Pharm Pract (2013) 0.76
Persistent hair growth during treatment with the EGFR inhibitor erlotinib. Dermatol Online J (2009) 0.76
Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience. Conn Med (2015) 0.76
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. J Transl Med (2014) 0.76
Peptide-based identification of functional motifs and their binding partners. J Vis Exp (2013) 0.76
Updates on immunotherapy in non-small cell lung cancer. Expert Opin Biol Ther (2014) 0.76
Catastrophic arteriovenous thromboembolism as initial manifestation of pancreatic cancer. JOP (2012) 0.76